# Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT

> **NCT06791746** · PHASE3 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 388 (actual)

## Conditions studied

- Stem Cell Transplant Complications
- Oral Mucositis

## Interventions

- **DRUG:** compound Staphylococcal lysostaphin mouthrinse
- **DRUG:** chlorhexidine mouthrinse

## Key facts

- **NCT ID:** NCT06791746
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-02
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 388 (ACTUAL)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06791746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06791746, "Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06791746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*